HHS to allow sale of unapproved peptides under review

The Department of Health and Human Services (HHS) will allow compounding pharmacies to manufacture and sell peptides that have not yet been added to the list of approved substances, advancing access to those championed by the "Make America Healthy Again" (MAHA) agenda. The HHS stated in a notice that it would be practicing enforcement discretion...

Summary aggregated from The Hill's public RSS feed. The full reporting belongs to The Hill — please read it on their site.